Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Dilmapimod

Next Previous
X
Search
Drug Profile

Dilmapimod

Alternative Names: 681323; GSK 681323; SB 681323

Latest Information Update: 05 Nov 2023

Price : $50 *
  • Adis is an information provider. We do not sell or distribute actual drugs.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase.
  • A link to download a PDF version of the drug profile will be included in your email receipt.

At a glance

  • Originator GlaxoSmithKline
  • Class Analgesics; Anti-inflammatories; Antibronchitics; Antirheumatics; Pyrimidines; Small molecules
  • Mechanism of Action P38 mitogen-activated protein kinase inhibitors
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity Yes

Highest Development Phases

  • Discontinued Acute lung injury; Adult respiratory distress syndrome; Atherosclerosis; Chronic obstructive pulmonary disease; Neuropathic pain; Rheumatoid arthritis

Most Recent Events

  • 16 Sep 2009 Efficacy, adverse event and pharmacodynamics data from a phase II trial in Chronic obstuctive pulmonary disease presented at the 19th Annual Congress of the European Respiratory Society (ERS-2009)
  • 06 Dec 2005 Phase-II clinical trials in Atherosclerosis in the UK
  • 30 Nov 2005 Phase-II clinical trials in Rheumatoid arthritis (PO)

You need to be a logged in or subscribed to view this content Request demo

If your organization or you do not have a subscription, try one of the following:
  • Contacting your organization’s admin about adding this content to your AdisInsight subscription
  • Buying a PDF version of any individual profile
  • Request a free trial
If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top